Institute of Liver and Biliary Sciences
New Delhi, National Capital Territory of Delhi, 110070, India
NCT Number: NCT02458079
Treatment for severe alcoholic hepatitis patients not eligible for steroid therapy is a dilemma. Pentoxyfilline has been shown to have no improvement in outcomes as per current studies and liver transplantation is with great risk of recidivism in this difficult to treat cohort of patients. Dysbiosis forms the central role in severe alcoholic hepatitis patients and modulation of gut microbiota by way of healthy donor fecal transplantation could prove to be a novel way to treating these patients who are ineligible for standard therapy. This study utilizes correction of dysbiosis in severe alcoholic hepatitis and surveys outcomes with the same with respect to survival and liver disease severity scores.
Looking for future studies?
Notify Me18 year–70 year
All sexes
Interventional
Not applicable
New Delhi, National Capital Territory of Delhi, 110070, India
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 3 months
Time frame: 3 month
Time frame: 3 month
Time frame: 3 month
Time frame: 30 days
Institute of Liver and Biliary Sciences, India
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02344680
Acquired Immunodeficiency Syndrome, Adenocarcinoma
Lusaka, Lusaka Province, Zambia
View Trial DetailsNCT03158818
Adenocarcinoma, Alcohol-Induced Disorders
Lusaka, Zambia
View Trial DetailsNCT05594953
Acute Liver Failure, Alcohol-Induced Disorders
Dallas, Texas, United States
View Trial DetailsNCT03149627
Alcohol-Induced Disorders, Alcohol-Related Disorders
Lusaka, Zambia
View Trial Details